Alan Chan
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
Papers in
-
- Extracellular vesicles in disease 5
-
- Nanoplatforms for cancer theranostics 14
- Co-authors
- Luis J. Cruz (39 shared papers)Clemens W.G.M. Löwik (22 shared papers)Ivo Que (22 shared papers)Ferry Ossendorp (8 shared papers)Thomas J. Snoeks (6 shared papers)Raimundo Fernandes de Araújo Júnior (11 shared papers)Timo Schomann (12 shared papers)Eric L. Kaijzel (11 shared papers)
- Journals
- Pharmaceutics (7 papers)Journal of Controlled Release (6 papers)Current Pharmaceutical Design (3 papers)Osteoarthritis and Cartilage (2 papers)Molecules (2 papers)
- Partner nations
- NetherlandsBrazilUnited States
In The Last Decade
Alan Chan
73 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 124
- Biomaterials 299
- Pharmaceutical Science 119
- Biomedical Engineering 712
- Cancer Research 201
- Hematology 152
Countries citing papers authored by Alan Chan
This map shows the geographic impact of Alan Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Chan more than expected).
Fields of papers citing papers by Alan Chan
This network shows the impact of papers produced by Alan Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Chan. The network helps show where Alan Chan may publish in the future.
Co-authors
The 25 scholars most cited alongside Alan Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 192 | |
| 2 | 2000 | 114 | |
| 3 | 2013 | 105 | |
| 4 | 2015 | 100 | |
| 5 | 2015 | 98 | |
| 6 | 2013 | 81 | |
| 7 | 2018 | 75 | |
| 8 | 2019 | 73 | |
| 9 | 2020 | 71 | |
| 10 | 2019 | 59 | |
| 11 | 2021 | 57 | |
| 12 | 2019 | 57 | |
| 13 | 2015 | 52 | |
| 14 | 2017 | 51 | |
| 15 | 2010 | 46 | |
| 16 | 2020 | 46 | |
| 17 | 2022 | 46 | |
| 18 | 2021 | 42 | |
| 19 | 2020 | 40 | |
| 20 | 2020 | 40 |
About Alan Chan
Alan Chan is a scholar working on Molecular Biology, Biomedical Engineering, Rheumatology, Oncology and Immunology, having authored 73 papers that have together received 2.3k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (14 papers), Osteoarthritis Treatment and Mechanisms (12 papers), Nanoparticle-Based Drug Delivery (7 papers), Photodynamic Therapy Research Studies (5 papers), Immunotherapy and Immune Responses (5 papers), Extracellular vesicles in disease (5 papers), Advanced Drug Delivery Systems (5 papers) and MicroRNA in disease regulation (5 papers). The work is most often cited by research in Biomaterials (299 citations), Pharmaceutical Science (119 citations), Biomedical Engineering (712 citations), Cancer Research (201 citations) and Hematology (152 citations). Alan Chan has collaborated with scholars based in Netherlands, Brazil and United States. Frequent co-authors include Luis J. Cruz, Clemens W.G.M. Löwik, Ivo Que, Ferry Ossendorp, Thomas J. Snoeks, Raimundo Fernandes de Araújo Júnior, Timo Schomann, Eric L. Kaijzel, Chih Kit Chung and Nigel Cook. Their work appears in journals such as Pharmaceutics, Journal of Controlled Release, Current Pharmaceutical Design, Osteoarthritis and Cartilage and Molecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.